The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Nov. 10, 2026
Filed:
Nov. 10, 2025
Applicant:
Mitsubishi Tanabe Pharma Corporation, Osaka, JP;
Inventors:
Motoyuki Nakajima, Osaka, JP;
Hiroaki Shitama, Osaka, JP;
Yuuki Arai, Osaka, JP;
Daiki Nakatake, Osaka, JP;
Hiroshi Miyazaki, Osaka, JP;
Yuzo Koda, Osaka, JP;
Assignee:
MITSUBISHI TANABE PHARMA CORPORATION, Osaka, JP;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 231/56 (2006.01); A61K 31/416 (2006.01); A61K 31/4192 (2006.01); A61K 31/422 (2006.01); A61K 31/4245 (2006.01); A61K 31/427 (2006.01); A61K 31/4439 (2006.01); A61K 31/4725 (2006.01); A61K 31/497 (2006.01); A61K 31/501 (2006.01); A61K 31/5377 (2006.01); C07D 401/14 (2006.01); C07D 403/14 (2006.01); C07D 405/14 (2006.01); C07D 409/14 (2006.01); C07D 413/14 (2006.01); C07D 417/04 (2006.01); C07D 417/14 (2006.01);
U.S. Cl.
CPC ...
C07D 231/56 (2013.01); A61K 31/416 (2013.01); A61K 31/4192 (2013.01); A61K 31/422 (2013.01); A61K 31/4245 (2013.01); A61K 31/427 (2013.01); A61K 31/4439 (2013.01); A61K 31/4725 (2013.01); A61K 31/497 (2013.01); A61K 31/501 (2013.01); A61K 31/5377 (2013.01); C07D 401/14 (2013.01); C07D 403/14 (2013.01); C07D 405/14 (2013.01); C07D 409/14 (2013.01); C07D 413/14 (2013.01); C07D 417/04 (2013.01); C07D 417/14 (2013.01);
Abstract
An object is to provide a novel compound capable of effectively inhibiting all of SIK1, SIK2, and SIK3, and a pharmaceutical composition including the compound. A compound represented by formula (I) below or a pharmacologically acceptable salt thereof is provided: wherein the symbols are as defined in the description.
Quick Actions:
Nakajima, Motoyuki. (2026). Salt-inducible kinase inhibitor compound and pharmaceutical composition including the same (U.S. Patent No. 12790303). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/12790303
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile